tradingkey.logo

Autonomix Medical Inc

AMIX
0.598USD
-0.002-0.28%
收盘 12/24, 13:00美东报价延迟15分钟
3.71M总市值
亏损市盈率 TTM

Autonomix Medical Inc

0.598
-0.002-0.28%

关于 Autonomix Medical Inc 公司

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Autonomix Medical Inc简介

公司代码AMIX
公司名称Autonomix Medical Inc
上市日期Jan 29, 2024
CEOHauser (Bradley)
员工数量8
证券类型Ordinary Share
年结日Jan 29
公司地址21 Waterway Ave, Suite 300
城市THE WOODLANDS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编77380
电话18322777816
网址https://autonomix.com/
公司代码AMIX
上市日期Jan 29, 2024
CEOHauser (Bradley)

Autonomix Medical Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Klemp (Walter V.)
2.18%
BioStar Ventures III, L.P.
1.75%
Heights Capital Management, Inc.
1.68%
Toth (Landy)
1.47%
Mariner Wealth Advisors
1.46%
其他
91.46%
持股股东
持股股东
占比
Klemp (Walter V.)
2.18%
BioStar Ventures III, L.P.
1.75%
Heights Capital Management, Inc.
1.68%
Toth (Landy)
1.47%
Mariner Wealth Advisors
1.46%
其他
91.46%
股东类型
持股股东
占比
Individual Investor
5.18%
Investment Advisor
3.53%
Corporation
1.75%
Hedge Fund
0.89%
Venture Capital
0.20%
Investment Advisor/Hedge Fund
0.15%
其他
88.29%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
39
329.96K
7.13%
--
2025Q3
39
329.96K
7.93%
+35.06K
2025Q2
35
294.92K
16.34%
-135.37K
2025Q1
30
430.29K
14.58%
+71.16K
2024Q4
29
489.76K
8.72%
+336.46K
2024Q3
25
18.30K
0.40%
+13.75K
2024Q2
19
4.55K
0.18%
+2.81K
2024Q1
10
1.66K
0.00%
+1.66K

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Klemp (Walter V.)
150.75K
2.43%
--
--
Sep 19, 2025
BioStar Ventures III, L.P.
120.82K
1.95%
--
--
Jun 30, 2025
Heights Capital Management, Inc.
116.09K
1.87%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
1.64%
--
--
Sep 19, 2025
Mariner Wealth Advisors
100.64K
1.62%
--
--
Jun 30, 2025
Foster (Jonathan P.)
36.56K
0.59%
--
--
Sep 19, 2025
Schwartz (Robert)
35.77K
0.58%
--
--
Sep 19, 2025
Ikarian Capital LLC
20.00K
0.32%
--
--
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
公告日期
类型
比率
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1

常见问题

Autonomix Medical Inc的前五大股东是谁?

Autonomix Medical Inc 的前五大股东如下:
Klemp (Walter V.)持有股份:150.75K,占总股份比例:2.43%。
BioStar Ventures III, L.P.持有股份:120.82K,占总股份比例:1.95%。
Heights Capital Management, Inc.持有股份:116.09K,占总股份比例:1.87%。
Toth (Landy)持有股份:101.31K,占总股份比例:1.64%。
Mariner Wealth Advisors持有股份:100.64K,占总股份比例:1.62%。

Autonomix Medical Inc的前三大股东类型是什么?

Autonomix Medical Inc 的前三大股东类型分别是:
Klemp (Walter V.)
BioStar Ventures III, L.P.
Heights Capital Management, Inc.

有多少机构持有Autonomix Medical Inc(AMIX)的股份?

截至2025Q4,共有39家机构持有Autonomix Medical Inc的股份,合计持有的股份价值约为329.96K,占公司总股份的7.13%。与2025Q3相比,机构持股有所增加,增幅为-0.80%。

哪个业务部门对Autonomix Medical Inc的收入贡献最大?

在--,--业务部门对Autonomix Medical Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI